Methods and means for assessing HIV envelope inhibitor therapy

Details Methods and means for assessing HIV envelope inhibitor therapy Methods and means for assessing HIV envelope inhibitor therapy

2007-12-11

2007-12-11

Chen, Stacy B. (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

C435S006120, C424S208100

Reexamination Certificate

active

10214670

ABSTRACT:
The present invention relates to methods and products for the evaluation of HIV treatment. In particular, molecular events at the HIV envelope protein and their effect on therapeutic efficacy of drugs are determined. The methods rely on providing HIV envelope nucleic acid material and evaluating a treatment either through genotyping or phenotyping. Said method may find use in multiple fields including diagnostics, drug screening, pharmacogenetics and drug development.

REFERENCES:
patent: 6033902 (2000-03-01), Haseltine et al.
patent: 1 043 407 (2000-10-01), None
patent: WO 94/17825 (1994-08-01), None
patent: WO 97/27480 (1997-07-01), None
patent: WO 00/66774 (2000-11-01), None
patent: WO 00/73511 (2000-12-01), None
patent: WO 01/57245 (2001-08-01), None
Zöllner et al. AIDS, May 4, 2001, vol. 15, Issue 7, pp. 935-936, internet printout pages numbered as pp. 1-3.
Holodniy, M. Business Briefings: Long-Term Healthcare, 2004, pp. 50-52 Available from website: http://www.bbriefings.com/cdps/cditem.cfm?NID=886.
Kellam et al. Recombinant Virus Assay, Antimicrobial Agents and Chemotherapy, 1994, vol. 38, No. 1, pp. 23-30.
Kilby et al. Potent suppression of HIV-1 replication in humans by T-20, Nature Medicine, 1998, vol. 4, No. 11, pp. 1302-1307.
PCT/IB97/00071, Int'l Search Report (2 sheets), Jul. 31, 1997, mailed Jun. 24, 1997.
PCT/EP00/04915, Int'l Search Report (4 sheets), Dec. 7, 2000, mailed Nov. 7, 2000.
PCT/US93/12088, Int'l Search Report (2 sheets), Aug. 18, 1994, mailed Mar. 29, 1994.

Affiliated with

Also associated with

Rating

Methods and means for assessing HIV envelope inhibitor therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and means for assessing HIV envelope inhibitor therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and means for assessing HIV envelope inhibitor therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3874457